This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma | MicrobiomeTrials
← Back to trials NCT06514898
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-05-05Est. Completion: 2027-09-01
Enrollment target: 12 participantsLocations University of Florida Health, Gainesville, Florida, United States Other microbiome trials you might be interested in Medulloblastoma
This randomized phase III trial is studying how well standard-dose radiation therapy works compared to reduced-dose radi…
Birmingham, United States Completed Mar 31, 2016
Brain Tumor
Dissemination of medulloblastoma is an independent risk factor of poor prognosis. Dissemination of medulloblastoma at re…
St Louis, United States Est. completion Feb 28, 2028